IPW
GILD icon

Impact Partnership Wealth’s Gilead Sciences GILD Stock Holding History

Impact Partnership Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Sell
2,268
-11,425
-83% -$1.51M 0.03% 352
2026
Q1 		$1.91M Sell
13,693
-1,548
-10% -$217K 0.24% 55
2025
Q4 		$1.87M Sell
15,241
-910
-6% -$111K 0.24% 46
2025
Q3 		$1.79M Buy
16,151
+3,013
+23% +$342K 0.27% 38
2025
Q2 		$1.46M Buy
13,138
+5,232
+66% +$557K 0.27% 35
2025
Q1 		$886K Sell
7,906
-5,044
-39% -$520K 0.19% 55
2024
Q4 		$1.2M Buy
12,950
+194
+2% +$17.5K 0.24% 47
2024
Q3 		$1.07M Sell
12,756
-198
-2% -$15.1K 0.24% 48
2024
Q2 		$889K Sell
12,954
-1,008
-7% -$67.3K 0.23% 52
2024
Q1 		$1.02M Buy
13,962
+4,375
+46% +$336K 0.41% 28
2023
Q4 		$777K Buy
9,587
+2,742
+40% +$213K 0.28% 46
2023
Q3 		$513K Buy
6,845
+2,708
+65% +$208K 0.16% 63
2023
Q2 		$319K Buy
+4,137
New +$330K 0.11% 132

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Impact Partnership Wealth's GILD Position: Q2 2026 in Review

Impact Partnership Wealth reduced its Gilead Sciences (GILD) stake by 83% in Q2 2026, selling an estimated $1.51M and leaving 2,268 shares worth $287K. The position accounts for 0.03% of the portfolio, ranked #352.

Impact Partnership Wealth first reported a position in GILD in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.91M in Q1 2026. 2,287 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Impact Partnership Wealth held 2,268 shares of Gilead Sciences worth $287K as of Q2 2026.
  • Impact Partnership Wealth sold 11,425 Gilead Sciences shares in Q2 2026, an estimated $1.51M.
  • Gilead Sciences made up 0.03% of Impact Partnership Wealth's portfolio in Q2 2026, its #352 holding.
  • Impact Partnership Wealth first reported a position in Gilead Sciences in Q2 2023 and has held it in 13 quarters since.
  • Impact Partnership Wealth's Gilead Sciences position peaked at $1.91M in Q1 2026.
  • 2,287 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Impact Partnership Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.